Cyclooxygenase-2 inhibitor is a robust enhancer of anticancer agents against hepatocellular carcinoma multicellular spheroids

PURPOSE: Celecoxib, an inhibitor of cyclooxygenase-2 (COX2), was investigated for enhancement of chemotherapeutic efficacy in cancer clinical trials. This study aimed to determine whether celecoxib combined with 5-fluorouracil or sorafenib or gefitinib is beneficial in HepG2 multicellular spheroids...

Descripción completa

Detalles Bibliográficos
Autores principales: Cui, Jie, Guo, Ya-Huan, Zhang, Hong-Yi, Jiang, Li-Li, Ma, Jie-Qun, Wang, Wen-Juan, Wang, Min-Cong, Yang, Cheng-Cheng, Nan, Ke-Jun, Song, Li-Ping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2014
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3938498/
https://www.ncbi.nlm.nih.gov/pubmed/24591842
http://dx.doi.org/10.2147/OTT.S56115

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3938498/
https://www.ncbi.nlm.nih.gov/pubmed/24591842
http://dx.doi.org/10.2147/OTT.S56115

Ejemplares similares